Table 1 All observed and expected cancers, along with standardized incidence ratio and 95% confidence interval
All cancers | Observed | Expected | SIR | 95% CI |
|---|---|---|---|---|
Stratified by sex | ||||
Male | 2.0 | 0.5 | 4.4 | 0.5, 16.0 |
Female | 12.0 | 2.6 | 4.6 | 2.4, 8.1 |
Stratified by age group | ||||
0 to 19 years | 3.0 | 0.8 | 3.9 | 0.8, 11.4 |
20+ years | 11.0 | 2.3 | 4.8 | 2.4, 8.6 |
Stratified by SLE duration | ||||
< 1 year | 2.0 | 0.1 | 15.2 | 1.8, 54.9 |
1 to 4 years | 1.0 | 0.6 | 1.8 | 0.0, 9.9 |
5 to 9 years | 1.0 | 0.6 | 1.7 | 0.0, 9.6 |
10 to 19 years | 8.0 | 0.9 | 9.2 | 4.0, 18.2 |
20+ years | 2.0 | 0.7 | 3.1 | 0.4, 11.1 |